2,510 followers
Open Access UCL Research: The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis https://t.co/1RWIzn7Q4Q
Open Access UCL Research: The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis https://t.co/1RWIzn7Q4Q